Predictions
Atari S.A.
Start price
Target price
Perf. (%)
€0.62
17.03.21
17.03.21
€0.80
17.03.22
17.03.22
-69.35%
18.03.22
18.03.22
Could be worthwhile Investment >10% per year
Westport Innovations Inc.
Start price
Target price
Perf. (%)
€1.31
20.02.22
20.02.22
€2.00
20.02.23
20.02.23
17.14%
17.03.22
17.03.22
Innovative
Differentiated customer and product portfolio
Known brand
Very Future proof/growth oriented business model
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€20.25
06.03.22
06.03.22
-
06.03.23
06.03.23
13.33%
17.03.22
17.03.22
Risky Investment
Baozun Inc ADR
Start price
Target price
Perf. (%)
€11.75
05.12.21
05.12.21
€4.00
05.12.22
05.12.22
-40.26%
16.03.22
16.03.22
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
SPI Energy Co Ltd ADR
Start price
Target price
Perf. (%)
€3.87
05.12.21
05.12.21
€1.90
05.12.22
05.12.22
-24.28%
16.03.22
16.03.22
Valuable balance sheet
Capable Management
Sustainability is not important
ROE lower than 10% per year
Aurora Cannabis Inc.
Start price
Target price
Perf. (%)
€5.22
05.12.21
05.12.21
€2.70
05.12.22
05.12.22
-44.67%
16.03.22
16.03.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
SNP Schneider-Neureither & Partner AG
Start price
Target price
Perf. (%)
€36.36
09.01.22
09.01.22
€27.00
09.01.23
09.01.23
-19.91%
16.03.22
16.03.22
high free float
Higher risks for its business
Very high cyclical dependencies
Little known brand
Frequentis AG
Start price
Target price
Perf. (%)
€26.00
24.01.22
24.01.22
€23.00
24.01.23
24.01.23
3.08%
16.03.22
16.03.22
Future proof or reliable business model
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Very low/no dividend yield expected
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€20.53
14.03.22
14.03.22
€14.00
14.03.23
14.03.23
3.70%
16.03.22
16.03.22
Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
Nano One Materials Corp
Start price
Target price
Perf. (%)
€2.77
16.09.21
16.09.21
-
16.09.22
16.09.22
-40.33%
16.03.22
16.03.22
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Below average Marketposition
Higher risks for its business
Cadiz Inc.
Start price
Target price
Perf. (%)
€5.35
01.11.21
01.11.21
-
01.11.22
01.11.22
-67.48%
16.03.22
16.03.22
Could be worthwhile Investment >10% per year
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€36.28
15.03.21
15.03.21
-
15.03.22
15.03.22
-43.36%
16.03.22
16.03.22
Lower EBIT Margin than peer group
Probably not worthwhile Investment
Revenue decline/stagnation expected
High valuation
Quantafuel ASA
Start price
Target price
Perf. (%)
€5.61
15.03.21
15.03.21
€6.00
15.03.22
15.03.22
-65.94%
16.03.22
16.03.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Beta Systems Software AG
Start price
Target price
Perf. (%)
€47.00
20.12.21
20.12.21
-
20.12.22
20.12.22
-16.17%
15.03.22
15.03.22
Hecla Mining Corp.
Start price
Target price
Perf. (%)
€5.04
27.11.21
27.11.21
€4.00
27.11.22
27.11.22
19.54%
14.03.22
14.03.22
Very low/no dividend yield expected
negative Cash Flow expected
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Canadian Solar Inc.
Start price
Target price
Perf. (%)
€26.94
20.12.21
20.12.21
€18.00
20.12.22
20.12.22
-0.33%
14.03.22
14.03.22
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€30.25
13.10.21
13.10.21
€34.00
30.07.22
30.07.22
-32.13%
14.03.22
14.03.22
Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€5.39
30.01.22
30.01.22
€4.00
30.01.23
30.01.23
-10.83%
14.03.22
14.03.22
Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year